Assessment of Lopinavir Pharmacokinetics With Respect to Developmental Changes in Infants and the Impact on Weight Band–Based Dosing

類似資料

• Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age: Pharmacokinetics and 24 Week Safety and Efficacy
  著者:: Chadwick, Ellen Gould, 等
  出版事項: (2009)
• Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy
  著者:: Chadwick, Ellen G., 等
  出版事項: (2011)
• Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors
  著者:: Robbins, Brian L., 等
  出版事項: (2008)
• Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development from Infancy through Adulthood
  著者:: Yang, Jincheng, 等
  出版事項: (2018)
• Population pharmacokinetics of siltuximab: Impact of disease state
  著者:: Nikanjam, Mina, 等
  出版事項: (2019)